NIAID Is Trying to Sideline the J&J Vaccines Because They Don’t Have a Patent on and Aren’t Making Money Off of Them like Pfizer and Moderna Vaccines (VIDEO)




Dr. Naomi Wolf, a Rhodes Scholar and former Clinton Administration advisor, joined Steve Bannon on The War Room on Saturday.
Earlier this week the Centers for Disease Control and Prevention (CDC) expressed their preference for Pfizer-BioNTech and Moderna’s mRNA COVID-19 vaccines over Johnson & Johnson’s jab.

Naomi Wolf knows why. The NIAID doesn’t hold the patents of the J&J vaccine.

Naomi Wolf: Moderna and Pfizer have been trying to sideline Johnson&Johnson partly because as Rob Kennedy will tell you, the stakeholders at the NIAID don’t have a patent on and don’t make money on the J&J vaccine. So they want it out of the marketplace. It’s not the first time they’ve said, “Oh that bad J&J vaccine.” …Anyone who’s looked at VAERS and saw the thousands of blood clots and thrombotic events, strokes, thrombotic events, for Pfizer and Moderna as well as J&J, knows this is absolute ludicrisy.

TRENDING: BREAKING: 6th Circuit Court Upholds Joe Biden’s OSHA Vaccine Mandate



Source link

Leave a Reply

Your email address will not be published.